Alzheimer’s Clinical Trials: What Families Need to Know
Join us for an informative discussion on the latest advancements in Alzheimer’s treatment, including newly approved infusion therapies and promising medications currently in clinical trials. Our expert speakers will explore the potential benefits, limitations, and considerations of these evolving options, helping families better understand what these developments may mean for their loved ones.
We will also take a closer look at widely marketed brain health products, such as Prevagen, and examine the science behind their claims. This engaging session is designed to provide clarity, credibility, and practical guidance in navigating today’s rapidly changing Alzheimer’s landscape.
- Sub-Headline With Neurologist Marie Kim, UCLA, & Our Kensington Caregiver Coaches
Speakers
-
Tami AnastasiaTami Anastasia is an Alzheimer’s and dementia counselor and educator, providing one-on-one caregiver support, guidance and strategies to help make the dementia journey easier on the caregiver. In addition to her work as a dementia counselor and consultant, Tami facilitates dementia caregiver support groups and conducts educational workshops and personalized one-on-one educational sessions.
-
Melissa LongMelissa Long coordinates support groups, caregiver workshops and educational events for caregivers and their loved ones on the journey with dementia. Melissa has been providing care to older adults for 17+ years.
-
Monica MooreMonica Moore, MSG is the Community Health Program Manager for the Mary S. Easton Center for Alzheimer’s Research and Care at UCLA and the Co-Director, Training and Education Activities, UCLA-California Alzheimer’s Disease Center. She has worked in the field of aging and Alzheimer’s disease for 20 years focusing on community education and outreach and caregiver support. She holds a master’s degree in Gerontology from California State University Long Beach and a certificate in Gerontology from Sonoma State University.
-
Marie Kim, NeurologistDr. Marie Kim is a board-certified neurologist with subspecialty training in Behavioral Neurology & Neuropsychiatry. She received her MD and PhD degree at the University of Iowa Carver College of Medicine Medical Scientist Training Program with a research focus in Immunology, specifically lymphocyte priming and kinetics. Her interest in synthesizing complex systems and integrating both the immune and nervous system for the development of new therapies led her to pursue clinical training in Neurology with a concentration in neurodegenerative dementia. She is committed to bridging innovation and patient care, combining her prior training to interpret a timely advent of new biomarkers and pipeline drugs for the benefit of individuals living with neurodegenerative disease.